Evidence map›Paper›PMID 25597952›Full record

ReviewThe Journal of steroid biochemistry and molecular biology2015

Effects of supplemental vitamin D and calcium on normal colon tissue and circulating biomarkers of risk for colorectal neoplasms.

Roberd M Bostick

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of steroid biochemistry and molecular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Roberd M BostickDepartment of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA. Electronic address: rmbosti@emory.edu.
Emory University · US

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Oxidative Stress, DNA Repair & Colorectal Adenoma RiskR01CA116795 · NCI · EMORY UNIVERSITY · PI GOODMAN, MICHAEL · 2007 to 2009
$869k
Calcium, Vitamin D, and Colon Cancer Risk BiomarkersR01CA104637 · NCI · EMORY UNIVERSITY · PI BOSTICK, ROBERD MANER · 2004 to 2005
$565k
Vitamin D/Calcium and Oxidative Stress and Inflammation BiomarkersR03CA136113 · NCI · EMORY UNIVERSITY · PI BOSTICK, ROBERD MANER · 2009 to 2010
$155k
Calcium, Vitamin D, and Markers of Adenomatous PolypsR03CA115230 · NCI · EMORY UNIVERSITY · PI BOSTICK, ROBERD MANER · 2005 to 2006
$151k
Vitamin D & Calcium Regulation Biomarkers in Colon Cancer Risk ReductionR03CA121873 · NCI · EMORY UNIVERSITY · PI BOSTICK, ROBERD MANER · 2006 to 2007
$151k
DIET, CELL PROLIFERATION, AND COLON NEOPLASIA STUDYR01CA066539 · NCI · WAKE FOREST UNIVERSITY · PI BOSTICK, ROBERD · 1994 to 1996
–
CALCIUM AND COLORECTAL EPITHELIAL CELL PROLIFERATIONR01CA051932 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI POTTER, JOHN D · 1990 to 1992
–
COLON CANCER PREVENTION RESEARCH UNITP01CA050305 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ELMER, PATRICIA J · 1990 to 1994
–
NCI NIH HHS P01 CA050305NCI NIH HHS P01CA50305NCI NIH HHS P30 CA138292NCI NIH HHS P30CA138292NCI NIH HHS R01 CA051932NCI NIH HHS R01 CA066539NCI NIH HHS R01 CA104637NCI NIH HHS R01CA104637NCI NIH HHS R01 CA116795NCI NIH HHS R01CA116795NCI NIH HHS R01CA51932NCI NIH HHS R01CA66539NCI NIH HHS R03 CA115230NCI NIH HHS R03CA115230NCI NIH HHS R03 CA121873NCI NIH HHS R03CA121873NCI NIH HHS R03 CA136113NCI NIH HHS R03CA136113
6 · The paper itself

Abstract

This brief review, based on an invited presentation at the 17th Workshop on Vitamin D, is to summarize a line of the author's research that has been directed at the intertwined missions of clarifying and/or developing vitamin D and calcium as preventive agents against colorectal cancer in humans, understanding the mechanisms by which these agents may reduce risk for the disease, and developing 'treatable' biomarkers of risk for colorectal cancer. The biological plausibility and observational and clinical trial evidence for vitamin D and calcium in reducing risk for colorectal neoplasms, the development of pre-neoplastic biomarkers of risk for colorectal neoplasms, and the clinical trial findings from the author's research group on the efficacy of vitamin D and calcium in modulating these biomarkers are summarized. Regarding the latter, we tested the efficacy of 800 IU (20μg) of vitamin D3 and 2.0g of calcium daily, alone and combined vs. placebo over 6 months on modulating normal colon tissue and circulating hypothesis-based biomarkers of risk for colorectal neoplasms in a randomized, double-blind, placebo-controlled, 2×2 factorial design clinical trial (n=92). The tissue-based biomarkers were measured in biopsies of normal-appearing rectal mucosa using immunohistochemistry with quantitative image analysis, and a panel of circulating inflammation markers was measured using enzyme-linked immunoassays (ELISA). Statistically significant proportional tissue increases in the vitamin D group relative to the placebo group were found in bax (51%), p21 (141%), APC (48%), E-cadherin (78%), MSH2 (179%), the CaSR (39%), and CYP27B1 (159%). In blood, there was a 77% statistically significant decrease in a summary inflammation z-score. The findings for calcium were similar to those for vitamin D. These findings indicate that supplemental vitamin D3 or calcium can favorably modulate multiple normal colon tissue and circulating hypothesis-based biomarkers of risk for colorectal neoplasms in sporadic colorectal adenoma patients. This article is part of a Special Issue entitled '17th Vitamin D Workshop'.

Indexed as

Dietary SupplementsBiomarkers, TumorCalcium, DietaryColonColorectal NeoplasmsHumansRisk FactorsVitamin DVitaminsBiomarkers, TumorCalcium, DietaryVitamin DVitaminsBiomarkers of riskCalciumColorectal neoplasmsVitamin D

Identifiers

PMID25597952
PMCPMC4389892
OpenAlexW2006892472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.